US equities
|
NVDA
$125.53
▼-14.01%
ANT
$88.91
▼-8.50%
MU
$594.51
▼-13.89%
AMD
$424.39
▼-13.25%
AAPL
$342.56
▼-1.90%
MSFT
$484.52
▼-2.77%
AMZN
$246.82
▼-4.10%
AVGO
$304.41
▼-12.19%
NVDA
$125.53
▼-14.01%
ANT
$88.91
▼-8.50%
MU
$594.51
▼-13.89%
AMD
$424.39
▼-13.25%
AAPL
$342.56
▼-1.90%
MSFT
$484.52
▼-2.77%
AMZN
$246.82
▼-4.10%
AVGO
$304.41
▼-12.19%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Reunion Neuroscience Inc/
Recent news which mentions Reunion Neuroscience Inc/
Hope For Postpartum Depression: This Company To Launch Clinical Trial On Next-Gen Psychedelic
September 18, 2023
Tickers
MSSTF
Tags
Legal
Psychedelics
Market News
From
Benzinga
Former Field Trip Health, Now Reunion Neuroscience: Q1 2023 Financial Results & Corporate Reorganization
August 16, 2022
Tags
Field Trip H&W
Benzinga
Joseph del Moral
From
Benzinga
Field Trip's Phase I Clinical Study Of Psilocybin Analog FT-104 Begins Dosing In Australia
July 21, 2022
Tags
Psychedelics
Dr/ Nathan Bryson
Field Trip Health Ltd
From
Benzinga
Field Trip Health To Divide Into Two Separate Public Companies
April 29, 2022
Tickers
FTRP
Tags
Reunion Neuroscience Inc/
Field Trip Digital
Oasis Managemente Company
From
Benzinga